Ryan Cohlhepp Bicara Therapeutics Inc. (BCAX) insider trading activity

Shares Held (Direct Ownership) 214K

n/a 3M change

n/a 12M change

Total Value Held N/A

Ryan Cohlhepp Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2025	BUY Exercise of conversion of derivative security	$111,000 $4.44 p/Share	25,000 Added 10.45%	214,141 Common Stock
Dec 15 2025	SELL Open market or private sale	$233,500 $18.68 p/Share	12,500 Reduced 6.2%	189,141 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	$30,320 $3.79 p/Share	8,000 Added 3.82%	201,641 Common Stock
Nov 21 2025	SELL Open market or private sale	$225,625 $18.05 p/Share	12,500 Reduced 6.06%	193,641 Common Stock
Nov 21 2025	BUY Exercise of conversion of derivative security	$30,320 $3.79 p/Share	8,000 Added 3.74%	206,141 Common Stock
Oct 15 2025	SELL Open market or private sale	$227,000 $18.16 p/Share	12,500 Reduced 5.93%	198,141 Common Stock
Oct 15 2025	BUY Exercise of conversion of derivative security	$30,320 $3.79 p/Share	8,000 Added 3.66%	210,641 Common Stock

Oct 07 2025	SELL Open market or private sale	$196,854 $18.06 p/Share	10,900 Reduced 5.1%	202,641 Common Stock
Oct 07 2025	BUY Exercise of conversion of derivative security	$30,320 $3.79 p/Share	8,000 Added 3.61%	213,541 Common Stock
Oct 06 2025	SELL Open market or private sale	$715,176 $18.06 p/Share	39,600 Reduced 16.15%	205,541 Common Stock
Oct 06 2025	BUY Exercise of conversion of derivative security	$90,960 $3.79 p/Share	24,000 Added 8.92%	245,141 Common Stock

President and COO

Boston, MA

Receive a notification when an Institution or Guru buys or sells BCAX shares.

Notify only if

Value

Get notified when an Bicara Therapeutics Inc. insider buys or sells BCAX shares.

Notify only if

Operation

Value

Type

Receive news related to Bicara Therapeutics Inc.